Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $166.06 +2.86%
EPS Growth %: -5.5%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -5.5%
Financial Fact:
Total operating expenses: 38.44M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q2 EPS of ($0.18), in-line with the analyst estimate of ($0.18).
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- ICON plc (ICLR) PT Raised to $150 at BofA Securities
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
